应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
EXAS 精密科学
交易中 04-26 12:56:12 EDT
59.09
+0.30
+0.51%
最高
60.31
最低
58.85
成交量
67.96万
今开
59.02
昨收
58.79
日振幅
2.48%
总市值
107.27亿
流通市值
106.10亿
总股本
1.82亿
成交额
4,042万
换手率
0.38%
流通股本
1.80亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
精密科学盘中异动 早盘大幅下跌5.11%报60.01美元
自选股智能写手 · 04-25 21:38
精密科学盘中异动 早盘大幅下跌5.11%报60.01美元
精密科学盘中异动 快速下挫5.02%
自选股智能写手 · 04-16
精密科学盘中异动 快速下挫5.02%
BUZZ-伯恩斯坦称 Freenome 的癌症检测研究数据更差是竞争对手的胜利
Reuters · 04-03
BUZZ-伯恩斯坦称 Freenome 的癌症检测研究数据更差是竞争对手的胜利
美国研究综述-模拟器件、Mosaic、Workday
Reuters · 02-22
美国研究综述-模拟器件、Mosaic、Workday
Exact Sciences Corp 预计每股亏损 46 美分 - 财报前瞻
Reuters · 02-20
Exact Sciences Corp 预计每股亏损 46 美分 - 财报前瞻
加载更多
公司概况
公司名称:
精密科学
所属市场:
NASDAQ
上市日期:
--
主营业务:
Exact Sciences Corporation是一家分子诊断公司,专注大肠癌的早期检测和预防。公司于1995年2月10日在特拉华州合并,拥有无创分子检测技术的自主知识产权,可检测大肠癌癌前病变和大肠癌。公司目标是成为关爱病人的诊断筛查产品的市场领军企业,生产用于大肠癌癌前病变和大肠癌早期检测的产品。为实现此目标,公司制定的战略路线包括以下几个要点:研发产品,通过美国食品药品管理局(FDA)的临床批准手续;使FDA批准的产品商业化,检测大肠癌癌前病变和大肠癌;从产品支付人那拿到可观的产品补偿。
发行价格:
--
{"stockData":{"symbol":"EXAS","market":"US","secType":"STK","nameCN":"精密科学","latestPrice":59.09,"timestamp":1714150562813,"preClose":58.79,"halted":0,"volume":679564,"delay":0,"floatShares":179558977,"shares":181530967,"eps":-1.133254,"marketStatus":"交易中","marketStatusCode":2,"change":0.3,"latestTime":"04-26 12:56:12 EDT","open":59.02,"high":60.31,"low":58.85,"amount":40416613.59212,"amplitude":0.024834,"askPrice":59.09,"askSize":1,"bidPrice":59.07,"bidSize":204,"shortable":3,"etf":0,"ttmEps":-1.133254,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1714161600000},"adr":0,"listingDate":980917200000,"adjPreClose":58.79,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":59.18,"preClose":58.79,"latestTime":"09:28 EDT","volume":464,"amount":27588.680432,"timestamp":1714138080054},"postHourTrading":{"tag":"盘后","latestPrice":59.38,"preClose":58.79,"latestTime":"19:52 EDT","volume":22798,"amount":1341161.298,"timestamp":1714089144588},"volumeRatio":0.680802},"requestUrl":"/m/hq/s/EXAS","defaultTab":"news","newsList":[{"id":"2430286839","title":"精密科学盘中异动 早盘大幅下跌5.11%报60.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430286839","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430286839?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:38","pubTimestamp":1714052309,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时38分,精密科学股票出现异动,股价大幅跳水5.11%。截至发稿,该股报60.01美元/股,成交量14.8036万股,换手率0.08%,振幅3.72%。最近的财报数据显示,该股实现营业收入25.00亿美元,净利润-2.04亿美元,每股收益-1.13美元,毛利17.53亿美元,市盈率-53.20倍。精密科学股票所在的生命科学行业中,整体跌幅为1.06%。Exact的Cologuard筛查测试是一种基于粪便的无创DNA测试,是一种结肠癌、直肠癌的癌前筛查测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521383079237609&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521383079237609&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427988732","title":"精密科学盘中异动 快速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427988732","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427988732?lang=zh_cn&edition=full","pubTime":"2024-04-16 02:11","pubTimestamp":1713204665,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日02时11分,精密科学股票出现波动,股价快速跳水5.02%。截至发稿,该股报67.76美元/股,成交量123.187万股,换手率0.68%,振幅5.65%。机构评级方面,在所有25家参与评级的机构中,92%的券商给予买入建议,8%的券商给予持有建议,无券商给予卖出建议。精密科学股票所在的生命科学行业中,整体跌幅为1.13%。Exact的Cologuard筛查测试是一种基于粪便的无创DNA测试,是一种结肠癌、直肠癌的癌前筛查测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416021106861e5df7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416021106861e5df7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424813435","title":"BUZZ-伯恩斯坦称 Freenome 的癌症检测研究数据更差是竞争对手的胜利","url":"https://stock-news.laohu8.com/highlight/detail?id=2424813435","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2424813435?lang=zh_cn&edition=full","pubTime":"2024-04-03 19:03","pubTimestamp":1712142205,"startTime":"0","endTime":"0","summary":" 4月3日 - ** 经纪公司伯恩斯坦称,Freenome公司基于血液的结直肠癌 筛查测试的试验结果不如预期,这消除了竞争对手Exact Sciences 和Guardant Health 的 \"重大隐患\"。** 我们现在知道 Freenome 的测试性能更差,因此在短期/中期内,它对 Shield 的威胁充其量是微弱的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413263298","title":"美国研究综述-模拟器件、Mosaic、Workday","url":"https://stock-news.laohu8.com/highlight/detail?id=2413263298","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413263298?lang=zh_cn&edition=full","pubTime":"2024-02-22 16:05","pubTimestamp":1708589139,"startTime":"0","endTime":"0","summary":" 路透社2月22日 - 华尔街证券分析师周四调整了对模拟器件、Mosaic 和 Workday 等几家美国上市公司的评级和目标价。* Nvidia Corp :BofA Global Research将目标股价从800美元上调至925美元 * Workday Inc :摩根大通将目标价从260美元上调至300美元 以下是路透社周四报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2412450168","title":"Exact Sciences Corp 预计每股亏损 46 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2412450168","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2412450168?lang=zh_cn&edition=full","pubTime":"2024-02-20 05:09","pubTimestamp":1708376979,"startTime":"0","endTime":"0","summary":" * 埃佳特科学公司 将于2月21日公布截至2023年12月31日的财报,预计该公司的季度收入将有所增长。 * LSEG 分析师对 Exact Sciences Corp 的平均预期是每股亏损 46 美分。* 华尔街对 Exact Sciences Corp 的 12 个月目标价中位数为 90.00 美元,高于上一次收盘价 60.97 美元。2月19日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.exactsciences.com","stockEarnings":[{"period":"1week","weight":-0.0739},{"period":"1month","weight":-0.0989},{"period":"3month","weight":-0.0854},{"period":"6month","weight":-0.0156},{"period":"1year","weight":-0.0621},{"period":"ytd","weight":-0.2053}],"compareEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":-0.0295},{"period":"3month","weight":0.033},{"period":"6month","weight":0.226},{"period":"1year","weight":0.2452},{"period":"ytd","weight":0.0593}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Exact Sciences Corporation是一家分子诊断公司,专注大肠癌的早期检测和预防。公司于1995年2月10日在特拉华州合并,拥有无创分子检测技术的自主知识产权,可检测大肠癌癌前病变和大肠癌。公司目标是成为关爱病人的诊断筛查产品的市场领军企业,生产用于大肠癌癌前病变和大肠癌早期检测的产品。为实现此目标,公司制定的战略路线包括以下几个要点:研发产品,通过美国食品药品管理局(FDA)的临床批准手续;使FDA批准的产品商业化,检测大肠癌癌前病变和大肠癌;从产品支付人那拿到可观的产品补偿。","yearOnYearQuotes":[{"month":1,"riseRate":0.521739,"avgChangeRate":0.094051},{"month":2,"riseRate":0.291667,"avgChangeRate":-0.062334},{"month":3,"riseRate":0.583333,"avgChangeRate":0.076896},{"month":4,"riseRate":0.416667,"avgChangeRate":0.017502},{"month":5,"riseRate":0.565217,"avgChangeRate":0.068331},{"month":6,"riseRate":0.652174,"avgChangeRate":0.100697},{"month":7,"riseRate":0.347826,"avgChangeRate":-0.017937},{"month":8,"riseRate":0.391304,"avgChangeRate":-0.002927},{"month":9,"riseRate":0.478261,"avgChangeRate":-0.006714},{"month":10,"riseRate":0.304348,"avgChangeRate":-0.044729},{"month":11,"riseRate":0.608696,"avgChangeRate":0.021238},{"month":12,"riseRate":0.608696,"avgChangeRate":0.06302}],"exchange":"NASDAQ","name":"精密科学","nameEN":"Exact Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"精密科学(EXAS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供精密科学(EXAS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"精密科学,EXAS,精密科学股票,精密科学股票老虎,精密科学股票老虎国际,精密科学行情,精密科学股票行情,精密科学股价,精密科学股市,精密科学股票价格,精密科学股票交易,精密科学股票购买,精密科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"精密科学(EXAS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供精密科学(EXAS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}